| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.450 | 21.870 | - | 26.866 | 37.280 | 35.667 | 36.949 | 43.157 | 57.986 | 68.245 |
| Total Income - EUR | 22.450 | 21.870 | - | 26.866 | 37.280 | 35.667 | 36.949 | 78.035 | 57.986 | 68.246 |
| Total Expenses - EUR | 16.653 | 14.477 | - | 18.729 | 20.461 | 20.117 | 20.713 | 58.074 | 19.361 | 39.713 |
| Gross Profit/Loss - EUR | 5.798 | 7.393 | - | 8.137 | 16.819 | 15.550 | 16.236 | 19.961 | 38.625 | 28.532 |
| Net Profit/Loss - EUR | 5.124 | 7.174 | - | 7.869 | 16.447 | 15.203 | 15.866 | 19.296 | 38.046 | 26.485 |
| Employees | 2 | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Bălan Ancuţa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51.844 | 42.978 | - | 38.882 | 37.995 | 36.794 | 39.381 | 5.719 | 6.957 | 7.536 |
| Current Assets | 9.422 | 4.215 | - | 17.365 | 30.165 | 41.630 | 49.296 | 41.330 | 56.449 | 46.173 |
| Inventories | 522 | 0 | - | 0 | 0 | 0 | 0 | 201 | 746 | 199 |
| Receivables | 4.701 | 1.861 | - | 2.184 | 6.483 | 9.139 | 6.455 | 33.131 | 50.007 | 22.596 |
| Cash | 4.200 | 2.354 | - | 15.181 | 23.682 | 32.491 | 42.841 | 7.998 | 5.696 | 23.378 |
| Shareholders Funds | 12.000 | 8.820 | - | 12.245 | 28.455 | 37.691 | 52.089 | 19.401 | 38.183 | 26.861 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 49.266 | 38.373 | - | 44.002 | 39.705 | 40.733 | 36.587 | 27.648 | 28.256 | 26.847 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Bălan Ancuţa Srl